Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas D Ross

Showing results (21-30 of 56) with videos related to

Pageof 6
Sort By:
Biochimica Et Biophysica Acta|July 2, 2011
Identification and characterization of the major alternative promoter regulating Bcrp1/Abcg2 expression in the mouse intestineKarthika Natarajan, Yi Xie, Takeo Nakanishi, et al.
Molecular Cancer Therapeutics|June 11, 2009
Suberoylanilide hydroxamic acid (Zolinza/vorinostat) sensitizes TRAIL-resistant breast cancer cells orthotopically implanted in BALB/c nude miceSharmila Shankar, Rachel Davis, Karan P Singh, et al.
Journal of Visualized Experiments : Jove|June 11, 2016
Methods to Discover Alternative Promoter Usage and Transcriptional Regulation of Murine Bcrp1Karthika Natarajan, Yi Xie, Takeo Nakanishi, et al.
Leukemia Research|January 22, 2005
A phase I and pharmacologic study of idarubicin, cytarabine, etoposide, and the multidrug resistance protein (MDR1/Pgp) inhibitor PSC-833 in patients with refractory leukemiaKenneth S Bauer, Judith E Karp, Tushar S Garimella, et al.
Biochimica Et Biophysica Acta|January 24, 2015
Functional cyclic AMP response element in the breast cancer resistance protein (BCRP/ABCG2) promoter modulates epidermal growth factor receptor pathway- or androgen withdrawal-mediated BCRP/ABCG2 transcription in human cancer cellsYi Xie, Takeo Nakanishi, Karthika Natarajan, et al.
International Journal of Molecular Medicine|November 8, 2005
Interactive effects of histone deacetylase inhibitors and TRAIL on apoptosis in human leukemia cells: involvement of both death receptor and mitochondrial pathwaysSharmila Shankar, Thiyam R Singh, Tamer E Fandy, et al.
Cancer Research|February 20, 2004
Identification of a novel estrogen response element in the breast cancer resistance protein (ABCG2) genePui Lai Rachel Ee, Sitharthan Kamalakaran, Debra Tonetti, et al.
Haematologica|October 16, 2012
Dasatinib targets chronic myeloid leukemia-CD34+ progenitors as effectively as it targets mature cellsDevendra K Hiwase, Verity A Saunders, Eva Nievergall, et al.
Leukemia & Lymphoma|January 15, 2015
Concomitant bone marrow involvement by plasma cell myeloma and primary myelodysplastic syndrome with biclonal complex chromosome anomaliesNahid M Nanaji, Qing C Chen, Zeba Singh, et al.
Biochemical Pharmacology|September 1, 2010
A novel xenobiotic responsive element regulated by aryl hydrocarbon receptor is involved in the induction of BCRP/ABCG2 in LS174T cellsLeslie M Tompkins, Haishan Li, Linhao Li, et al.
Pageof 6

Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
Biochimica Et Biophysica Acta|July 2, 2011
Identification and characterization of the major alternative promoter regulating Bcrp1/Abcg2 expression in the mouse intestineKarthika Natarajan, Yi Xie, Takeo Nakanishi, et al.
Molecular Cancer Therapeutics|June 11, 2009
Suberoylanilide hydroxamic acid (Zolinza/vorinostat) sensitizes TRAIL-resistant breast cancer cells orthotopically implanted in BALB/c nude miceSharmila Shankar, Rachel Davis, Karan P Singh, et al.
Journal of Visualized Experiments : Jove|June 11, 2016
Methods to Discover Alternative Promoter Usage and Transcriptional Regulation of Murine Bcrp1Karthika Natarajan, Yi Xie, Takeo Nakanishi, et al.
Leukemia Research|January 22, 2005
A phase I and pharmacologic study of idarubicin, cytarabine, etoposide, and the multidrug resistance protein (MDR1/Pgp) inhibitor PSC-833 in patients with refractory leukemiaKenneth S Bauer, Judith E Karp, Tushar S Garimella, et al.
Biochimica Et Biophysica Acta|January 24, 2015
Functional cyclic AMP response element in the breast cancer resistance protein (BCRP/ABCG2) promoter modulates epidermal growth factor receptor pathway- or androgen withdrawal-mediated BCRP/ABCG2 transcription in human cancer cellsYi Xie, Takeo Nakanishi, Karthika Natarajan, et al.
International Journal of Molecular Medicine|November 8, 2005
Interactive effects of histone deacetylase inhibitors and TRAIL on apoptosis in human leukemia cells: involvement of both death receptor and mitochondrial pathwaysSharmila Shankar, Thiyam R Singh, Tamer E Fandy, et al.
Cancer Research|February 20, 2004
Identification of a novel estrogen response element in the breast cancer resistance protein (ABCG2) genePui Lai Rachel Ee, Sitharthan Kamalakaran, Debra Tonetti, et al.
Haematologica|October 16, 2012
Dasatinib targets chronic myeloid leukemia-CD34+ progenitors as effectively as it targets mature cellsDevendra K Hiwase, Verity A Saunders, Eva Nievergall, et al.
Leukemia & Lymphoma|January 15, 2015
Concomitant bone marrow involvement by plasma cell myeloma and primary myelodysplastic syndrome with biclonal complex chromosome anomaliesNahid M Nanaji, Qing C Chen, Zeba Singh, et al.
Biochemical Pharmacology|September 1, 2010
A novel xenobiotic responsive element regulated by aryl hydrocarbon receptor is involved in the induction of BCRP/ABCG2 in LS174T cellsLeslie M Tompkins, Haishan Li, Linhao Li, et al.
Pageof 6